Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 984 of 1,261
  1. US 7820733

    Dental polymerizable core build-up material of separately packed type

    Kuraray Medical Inc. · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  2. US 7820695

    Selective serotonin receptor inverse agonists as therapeutics for disease

    ACADIA Pharmaceuticals Inc. · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  3. US 7820634

    Composition and method for production of transformed cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  4. US 7820819

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  5. US 7820181

    Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  6. US 7820182

    Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  7. US 7820447

    Compositions and methods for cancer

    Sagres Discovery, Inc. · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  8. US 7820642

    Nandrolone 17β-carbonates

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  9. US 2010267717

    Novel Heterocyclic NF-kB Inhibitors

    4SC AG [DE] · Granted Oct 21, 2010 · Expires Oct 16, 2030

    granted
  10. US 7816352

    Apoptosis inhibitors

    The Regents of the University of California · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted
  11. US 7816075

    Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted
  12. US 7815914

    Methods for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted
  13. US 7816086

    Genes of an otitis media isolate of nontypeable Haemophilus influenzae

    The Board of Regents of the University of Oklahoma · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted
  14. US 7815921

    Cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and antimicrobial treatment following high-dose cytotoxic chemotherapy

    Ludwig-Maximilians-Universitat Munchen · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted
  15. US 7816532

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted
  16. US 7816529

    Pyrimidines useful as modulators of voltage-gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted
  17. US 7816538

    Dimeric small molecule potentiators of apoptosis

    The Board of Regents of the University of Texas System · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted
  18. US 7815434

    Dental coating kit

    Kuraray Medical Inc. · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted
  19. US 7816560

    Long chain n-alkyl compounds and oxa-derivatives thereof

    United Therapeutics Corporation · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted
  20. US 7816324

    Composition and method for the treatment of diseases affected by a peptide receptor

    The Board of Regents of the University of Texas System · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted
  21. US 7816372

    6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds

    Ligand Pharmaceuticals Incorporated · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted
  22. US 7815935

    Orally distintegrating formulation and process for preparing the same

    Quantum Hi-Tech (Beijing) Research Institute · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted
  23. US 7816076

    Therapeutic targets in cancer

    Sagres Discovery, Inc. · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted
  24. US 7816087

    Gene expressed in prostate cancer and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.